This analysis revealed strong positive correlations between RNF220 expression and key biological processes in hematological malignancies, including tumorigenesis, apoptosis, differentiation, and epithelial–mesenchymal transition (EMT). The gene discussed is RNF220; the disease is hematologic disorder.